(Q37121648)

English

Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer

scientific article published on 14 July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

neoadjuvant chemotherapy

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lisa K Dunnwald

1

1 reference

Europe PubMed Central

18 August 2017

Julie R Gralow

2

1 reference

Europe PubMed Central

18 August 2017

Georgiana K Ellis

3

1 reference

Europe PubMed Central

18 August 2017

Robert B Livingston

4

1 reference

Europe PubMed Central

18 August 2017

Hannah M Linden

5

1 reference

Europe PubMed Central

18 August 2017

Jennifer M Specht

6

1 reference

Europe PubMed Central

18 August 2017

Robert K Doot

7

1 reference

Europe PubMed Central

18 August 2017

Thomas J Lawton

8

1 reference

Europe PubMed Central

18 August 2017

William E Barlow

9

1 reference

Europe PubMed Central

18 August 2017

Brenda F Kurland

10

1 reference

Europe PubMed Central

18 August 2017

Erin K Schubert

11

1 reference

Europe PubMed Central

18 August 2017

David A Mankoff

12

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

14 July 2008

1 reference

Europe PubMed Central

18 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

18 August 2017

26

1 reference

Europe PubMed Central

18 August 2017

27

1 reference

Europe PubMed Central

18 August 2017

4449-4457

1 reference

Europe PubMed Central

18 August 2017

describes a project that uses

positron emission tomography

1 reference

based on heuristic

inferred from title

Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

14 September 2017

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

14 September 2017

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

14 September 2017

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

14 September 2017

Prognostic factors. Stage and receptor status in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

14 September 2017

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

14 September 2017

Pathological assessment of response to induction chemotherapy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

14 September 2017

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

29 September 2017

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

27 June 2018

The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

27 June 2018

Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Sequential positron emission tomography using [18F]fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

The relationship between vascular and metabolic characteristics of primary breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Risk of Mortality by Histologic Type of Breast Cancer Among Women Aged 50 to 79 Years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653115

3 September 2018

Breast carcinoma: measurement of tumor response to primary medical therapy with color Doppler flow imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18626006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2007.15.4385

1 reference

Europe PubMed Central

18 August 2017

release_qgnq5lkmkbag3lovxermidi44a

1 reference

https://api.fatcat.wiki/v0/release/qgnq5lkmkbag3lovxermidi44a

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37121648&oldid=2126793838"